Piramal Pharma Limited was incorporated on March 4 ... the equity shareholders of PEL as on the demerger record date received 4 equity shares of face and paid-up value of Rs 10 each of the ...

Piramal Pharma Limited said, "FY25 so far has been a steady year for the Company with revenue growth of 14% and EBITDA growing at 20%. Our CDMO business continues to deliver robust performance ...

Jio Financial Services got demerged from Reliance Industries. It took 33 days for the listing post the record date. Piramal Pharma took 45 days for the listing post its demerger (record date ...

Piramal Pharma Ltd, which has a strong presence in the inhaled anaesthetic generics segment in the US and emerging markets, plans to expand its pipeline of injectables to drive growth, chairperson ...

Piramal Pharma Ltd. announced a net profit of ₹3.7 crore in Q3 FY25, against ₹10.1 crore in the corresponding period in FY24, after decreasing 63.4% YoY. Operating revenues of ₹2,204.2 crore ...

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17 * global development and manufacturing facilities and a global ...